REQUEST A DEMO
Total
USD $0.00
Search more companies

Guizhou Bailing Group Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Guizhou Bailing Group Pharmaceutical Co., Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is a leading network in communications equipment, network terminals, video products, information, software and other integrated solutions in education, telecommunications, finance, postal, government, business, medical, military, transportation and other areas of information technology, providing the most thoughtful application solutions. MODEM and ADSL product for many years in the domestic sales, entitled "Chinese Elvis" and "China's A Cat brand", owning more than 70% of wireless public telephone business phone market share. The development of Ethernet-based Passive Optical Network (EPON) system environment optical network unit (ONU) products. And TI, Broadcom, Motorola, Microsoft, AMD, Intel, Siemens, Marvell, Benq and other upstream firms to establish a wide range of technical cooperation.

Headquarters
No. 212, Xihang Road, Economic and Technological Development Zone, Anshun City, Guizhou Province
Anshun; Guizhou; Postal Code: 561000

Contact Details: Purchase the Guizhou Bailing Group Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.gzbl.com

Basic Information
Total Employees:
Purchase the Guizhou Bailing Group Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Guizhou Bailing Group Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Guizhou Bailing Group Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Guizhou Bailing Group Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
April 04, 2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
17.39%
Purchase this report to view the information.
6.15%
Purchase this report to view the information.
5.28%
Purchase this report to view the information.
0.61%
Purchase this report to view the information.
0.57%
Subsidiaries
Anshun Great Health Pharmaceutical Industry Operation Co., Ltd.
Anshun Petrochina Kunlun Bailing Gas Co., Ltd.
Bailing Chinese Medicine Diabetes Hospital (Changsha) Co., Ltd.
Company Performance
Financial values in the chart are available after Guizhou Bailing Group Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-1.22%
Total operating revenue
-2.12%
Operating profit (EBIT)
-23.77%
Net Profit (Loss) for the Period
-38.17%
Total assets
-0.05%
Total equity
-13.7%
Operating Profit Margin (ROS)
-1.37%
Net Profit Margin
-1.87%
Return on Equity (ROE)
-0.99%
Debt to Equity Ratio
2.8%
Quick Ratio
-0.27%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?